The present findings revealed that MDA-7/IL-24 treatment of melanoma cells activates phosphorylation of STAT3 and down-regulates interferon regulatory factor (IRF-1) whereas up-regulating IRF-2 expression, which reduces iNOS expression level [25], [30]. The gene discussed is NOS2; the disease is melanoma.